title: Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline.
authors.affiliation: Struttura Ambulatoriale di Endocrinologia, A.O. Spedali Civili di Brescia, University of Brescia, Via Biseo 17, 25100, Brescia, Italy, a.giustina@libero.it.
authors.forename: A
authors.initials: A
authors.lastname: Giustina
authors.forename: M R
authors.initials: MR
authors.lastname: Ambrosio
authors.forename: P
authors.initials: P
authors.lastname: Beck Peccoz
authors.forename: F
authors.initials: F
authors.lastname: Bogazzi
authors.forename: S
authors.initials: S
authors.lastname: Cannavo'
authors.forename: L
authors.initials: L
authors.lastname: De Marinis
authors.forename: E
authors.initials: E
authors.lastname: De Menis
authors.forename: S
authors.initials: S
authors.lastname: Grottoli
authors.forename: R
authors.initials: R
authors.lastname: Pivonello
mesh_terms: D000172:Acromegaly / Q000188:drug therapy*; D004704:Endocrinology / Q000592:standards*; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D007558:Italy; D017410:Practice Guidelines as Topic / Q000592:standards*; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors*
chemical_list: D011986:Receptors, Somatotropin; D019382:Human Growth Hormone; C406545:pegvisomant